Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators.
Cardiovascular magnetic resonance imaging
Implantable cardioverter-defibrillator
Left atrial function
Left atrial volume
Outcomes
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
01
01
2021
accepted:
15
02
2021
pubmed:
2
3
2021
medline:
16
10
2021
entrez:
1
3
2021
Statut:
ppublish
Résumé
Left atrial (LA) volume and function (LA ejection fraction, LAEF) have demonstrated prognostic value in various cardiovascular diseases. We investigated the incremental value of LA volume and LAEF as measured by cardiovascular magnetic resonance imaging (CMR) for prediction of appropriate implantable cardioverter defibrillator (ICD) shock or all-cause mortality, in patients with ICD. We conducted a retrospective, multi-centre observational cohort study of patients who underwent CMR prior to primary or secondary prevention ICD implantation. A single, blinded reader measured maximum LA volume index (maxLAVi), minimum LA volume index (minLAVi), and LAEF. The primary outcome was a composite of independently adjudicated appropriate ICD shock or all-cause death. A total of 392 patients were enrolled. During a median follow-up time of 61 months, 140 (35.7%) experienced an appropriate ICD shock or died. Higher maxLAVi and minLAVi, and lower LAEF were associated with greater risk of appropriate ICD shock or death in univariate analysis. However, in multivariable analysis, LAEF (HR 0.92 per 10% higher, 95% CI 0.81-1.04, p = 0.17) and maxLAVi (HR 1.02 per 10 ml/m
Identifiants
pubmed: 33646496
doi: 10.1007/s10554-021-02196-1
pii: 10.1007/s10554-021-02196-1
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
2259-2267Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.
Références
Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB et al (2018) 2017 AHA/ACC/HRS 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart Rhythm society. J Am Coll Cardiol 72(14):1677–1749. https://doi.org/10.1016/j.jacc.2017.10.053
doi: 10.1016/j.jacc.2017.10.053
pubmed: 29097294
Goldberger JJ, Subacius H, Patel T, Cunnane R, Kadish AH (2014) Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 63(18):1879–1889. https://doi.org/10.1016/j.jacc.2013.12.021
doi: 10.1016/j.jacc.2013.12.021
pubmed: 24445228
Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237. https://doi.org/10.1056/NEJMoa043399
doi: 10.1056/NEJMoa043399
pubmed: 15659722
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883. https://doi.org/10.1056/NEJMoa013474
doi: 10.1056/NEJMoa013474
pubmed: 11907286
Ezekowitz JA, Rowe BH, Dryden DM, Hooton N, Vandermeer B, Spooner C et al (2007) Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction. Ann Intern Med 147(4):251–262. https://doi.org/10.7326/0003-4819-147-4-200708210-00007
doi: 10.7326/0003-4819-147-4-200708210-00007
pubmed: 17709759
Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT et al (2009) Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation 120(10):835–842. https://doi.org/10.1161/CIRCULATIONAHA.108.816884
doi: 10.1161/CIRCULATIONAHA.108.816884
pubmed: 19704100
pmcid: 3774781
Sabbag A, Suleiman M, Laish-Farkash A, Samania N, Kazatsker M, Goldenberg I et al (2015) Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: from the Israeli ICD Registry. Heart Rhythm 12(12):2426–2433. https://doi.org/10.1016/j.hrthm.2015.08.020
doi: 10.1016/j.hrthm.2015.08.020
pubmed: 26277863
Kober L, Thune JJ, Nielsen JC, Haarbo J, Videbaek L, Korup E et al (2016) DefibrillatorDefibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375(13):1221–1230. https://doi.org/10.1056/NEJMoa1608029
doi: 10.1056/NEJMoa1608029
pubmed: 27571011
Santangeli P, Dello Russo A, Casella M, Pelargonio G, Di Biase L, Natale A (2011) Left ventricular ejection fraction for the risk stratification of sudden cardiac death: friend or foe? Intern Med J 41(1a):55–60. https://doi.org/10.1111/j.1445-5994.2010.02371.x
doi: 10.1111/j.1445-5994.2010.02371.x
pubmed: 21265961
Almehmadi F, Joncas SX, Nevis I, Zahrani M, Bokhari M, Stirrat J et al (2014) Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy. Circ Cardiovasc Imaging 7(4):593–600. https://doi.org/10.1161/CIRCIMAGING.113.001768
doi: 10.1161/CIRCIMAGING.113.001768
pubmed: 24902587
Gulati A, Jabbour A, Ismail TF, Guha K, Khwaja J, Raza S et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309(9):896–908. https://doi.org/10.1001/jama.2013.1363
doi: 10.1001/jama.2013.1363
pubmed: 23462786
Haghbayan H, Lougheed N, Deva DP, Chan KKW, Lima JAC, Yan AT (2019) Peri-Infarct quantification by cardiac magnetic resonance to predict outcomes in ischemic cardiomyopathy: prognostic systematic review and meta-analysis. Circ Cardiovasc Imaging 12(11):e009156. https://doi.org/10.1161/CIRCIMAGING.119.009156
doi: 10.1161/CIRCIMAGING.119.009156
pubmed: 31735067
Hoit BD (2014) Left atrial size and function: role in prognosis. J Am Coll Cardiol 63(6):493–505. https://doi.org/10.1016/j.jacc.2013.10.055
doi: 10.1016/j.jacc.2013.10.055
pubmed: 24291276
Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90(12):1284–1289. https://doi.org/10.1016/s0002-9149(02)02864-3
doi: 10.1016/s0002-9149(02)02864-3
pubmed: 12480035
Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol. 1993;22(7):1972–82. https://doi.org/10.1016/0735-1097(93)90787-2 .
Geske JB, Sorajja P, Nishimura RA, Ommen SR (2009) The relationship of left atrial volume and left atrial pressure in patients with hypertrophic cardiomyopathy: an echocardiographic and cardiac catheterization study. J Am Soc Echocardiogr 22(8):961–966. https://doi.org/10.1016/j.echo.2009.05.003
doi: 10.1016/j.echo.2009.05.003
pubmed: 19524402
Guron CW, Hartford M, Rosengren A, Thelle D, Wallentin I, Caidahl K (2005) Usefulness of atrial size inequality as an indicator of abnormal left ventricular filling. Am J Cardiol 95(12):1448–1452. https://doi.org/10.1016/j.amjcard.2005.02.011
doi: 10.1016/j.amjcard.2005.02.011
pubmed: 15950568
Lydell CP, Mikami Y, Homer K, Peng M, Cornhill A, Rajagopalan A et al (2019) Left atrial function using cardiovascular magnetic resonance imaging independently predicts life-threatening arrhythmias in patients referred to receive a primary prevention implantable cardioverter defibrillator. Can J Cardiol 35(9):1149–1157. https://doi.org/10.1016/j.cjca.2019.04.015
doi: 10.1016/j.cjca.2019.04.015
pubmed: 31472813
Rijnierse MT, Kamali Sadeghian M, Schuurmans Stekhoven S, Biesbroek PS, van der Lingen AC, van de Ven PM et al (2017) Usefulness of left atrial emptying fraction to predict ventricular arrhythmias in patients with implantable cardioverter defibrillators. Am J Cardiol 120(2):243–250. https://doi.org/10.1016/j.amjcard.2017.04.015
doi: 10.1016/j.amjcard.2017.04.015
pubmed: 28532781
Ren JF, Kotler MN, DePace NL, Mintz GS, Kimbiris D, Kalman P et al (1983) Two-dimensional echocardiographic determination of left atrial emptying volume: a noninvasive index in quantifying the degree of nonrheumatic mitral regurgitation. J Am Coll Cardiol 2(4):729–736. https://doi.org/10.1016/s0735-1097(83)80313-1
doi: 10.1016/s0735-1097(83)80313-1
pubmed: 6886234
Maceira AM, Prasad SK, Khan M, Pennell DJ (2006) Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8(3):417–426
doi: 10.1080/10976640600572889
Fatema K, Barnes ME, Bailey KR, Abhayaratna WP, Cha S, Seward JB, et al. Minimum vs. maximum left atrial volume for prediction of first atrial fibrillation or flutter in an elderly cohort: a prospective study. Eur J Echocardiogr. 2009;10(2):282–6. https://doi.org/10.1093/ejechocard/jen235 .
Habibi M, Samiei S, Ambale Venkatesh B, Opdahl A, Helle-Valle TM, Zareian M, et al. Cardiac magnetic resonance-measured left atrial volume and function and incident atrial fibrillation: results from MESA (Multi-Ethnic Study of Atherosclerosis). Circ Cardiovasc Imaging. 2016;9(8). https://doi.org/10.1161/CIRCIMAGING.115.004299 .
Pellicori P, Zhang J, Lukaschuk E, Joseph AC, Bourantas CV, Loh H et al (2015) Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value. Eur Heart J 36(12):733–742. https://doi.org/10.1093/eurheartj/ehu405
doi: 10.1093/eurheartj/ehu405
pubmed: 25336215
Huang JL, Tai CT, Lin YJ, Ting CT, Chen YT, Chang MS et al (2006) The mechanisms of an increased dominant frequency in the left atrial posterior wall during atrial fibrillation in acute atrial dilatation. J Cardiovasc Electrophysiol 17(2):178–188. https://doi.org/10.1111/j.1540-8167.2005.00297.x
doi: 10.1111/j.1540-8167.2005.00297.x
pubmed: 16533256
Kayatas M, Ozdemir FN, Muderrisoglu H, Korkmaz ME (1999) Diastolic dysfunction increases the frequency of ventricular arrhythmia in hemodialysis patients. Nephron 82(2):185–187. https://doi.org/10.1159/000045398
doi: 10.1159/000045398
pubmed: 10364713
Mordi I, Jhund PS, Gardner RS, Payne J, Carrick D, Berry C et al (2014) LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs. JACC Cardiovasc Imaging 7(6):561–569. https://doi.org/10.1016/j.jcmg.2013.12.014
doi: 10.1016/j.jcmg.2013.12.014
pubmed: 24813968
Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–867. https://doi.org/10.1093/eurheartj/ehv316 .
Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ (2000) Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2(4):271–278. https://doi.org/10.3109/10976640009148691
doi: 10.3109/10976640009148691
pubmed: 11545126
Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU et al (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90(1):29–34. https://doi.org/10.1016/s0002-9149(02)02381-0
doi: 10.1016/s0002-9149(02)02381-0
pubmed: 12088775
Rodevan O, Bjornerheim R, Ljosland M, Maehle J, Smith HJ, Ihlen H (1999) Left atrial volumes assessed by three- and two-dimensional echocardiography compared to MRI estimates. Int J Card Imaging 15(5):397–410
doi: 10.1023/A:1006276513186
Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S (2005) Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7(5):775–782. https://doi.org/10.1080/10976640500295516
doi: 10.1080/10976640500295516
pubmed: 16353438
Sievers B, Kirchberg S, Addo M, Bakan A, Brandts B, Trappe HJ (2004) Assessment of left atrial volumes in sinus rhythm and atrial fibrillation using the biplane area-length method and cardiovascular magnetic resonance imaging with TrueFISP. J Cardiovasc Magn Reson 6(4):855–863. https://doi.org/10.1081/jcmr-200036170
doi: 10.1081/jcmr-200036170
pubmed: 15646889
Jiamsripong P, Honda T, Reuss CS, Hurst RT, Chaliki HP, Grill DE et al (2008) Three methods for evaluation of left atrial volume. Eur J Echocardiogr 9(3):351–355. https://doi.org/10.1016/j.euje.2007.05.004
doi: 10.1016/j.euje.2007.05.004
pubmed: 17658300